Trial Details

COMPLETED
Basic Information
Clinical ID c1821
Identifier NCT04397263
Trial Title A Study of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
Trial URL Visit Original Page
Study Information
Study Results

YES
Conditions Crohns Disease
Interventions DRUG: Guselkumab
Participant Information
Sponsor Janssen Pharmaceutical K.K.
City Abiko
Country/Region Japan
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2020-06-10
Primary Completion Date 2024-02-29
Completion Date 2025-09-12